BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29971447)

  • 1. Ultra-Wide-Field Fluorescein Angiography-Guided Normalization of Ischemic Index Calculation in Eyes With Retinal Vein Occlusion.
    Wang K; Ghasemi Falavarjani K; Nittala MG; Sagong M; Wykoff CC; van Hemert J; Ip M; Sadda SR
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3278-3285. PubMed ID: 29971447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in retinal ischaemic index correlate with recalcitrant macular oedema in retinal vein occlusion: WAVE study.
    Kwon S; Wykoff CC; Brown DM; van Hemert J; Fan W; Sadda SR
    Br J Ophthalmol; 2018 Aug; 102(8):1066-1071. PubMed ID: 29699979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of Nonperfusion Area on Ultra-widefield Fluorescein Angiography in Eyes With Diabetic Macular Edema: DAVE Study.
    Fan W; Wang K; Ghasemi Falavarjani K; Sagong M; Uji A; Ip M; Wykoff CC; Brown DM; van Hemert J; Sadda SR
    Am J Ophthalmol; 2017 Aug; 180():110-116. PubMed ID: 28579062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ranibizumab alone versus ranibizumab with targeted retinal laser for branch retinal vein occlusion with macular edema.
    Goel S; Kumar A; Ravani RD; Chandra P; Chandra M; Kumar V
    Indian J Ophthalmol; 2019 Jul; 67(7):1105-1108. PubMed ID: 31238421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Area of peripheral retinal nonperfusion and treatment response in branch and central retinal vein occlusion.
    Singer M; Tan CS; Bell D; Sadda SR
    Retina; 2014 Sep; 34(9):1736-42. PubMed ID: 24732695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship Between Visual Acuity and Retinal Thickness During Anti-Vascular Endothelial Growth Factor Therapy for Retinal Diseases.
    Ou WC; Brown DM; Payne JF; Wykoff CC
    Am J Ophthalmol; 2017 Aug; 180():8-17. PubMed ID: 28549848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Retinal Microvasculature and Visual Acuity After Antivascular Endothelial Growth Factor Therapy in Retinal Vein Occlusion.
    Winegarner A; Wakabayashi T; Fukushima Y; Sato T; Hara-Ueno C; Busch C; Nishiyama I; Shiraki N; Sayanagi K; Nishida K; Sakaguchi H; Nishida K
    Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):2708-2716. PubMed ID: 29860457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral Laser for Recalcitrant Macular Edema Owing to Retinal Vein Occlusion: The WAVE Trial.
    Wykoff CC; Ou WC; Wang R; Brown DM; Cone C; Zamora D; Le RT; Sagong M; Wang K; Sadda SR;
    Ophthalmology; 2017 Jun; 124(6):919-921. PubMed ID: 28318636
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of leaking capillaries and microaneurysms in the perifoveal capillary network on resolution of macular edema by anti-vascular endothelial growth factor treatment.
    Iesato Y; Imai A; Hirano T; Toriyama Y; Murata T
    Jpn J Ophthalmol; 2016 Mar; 60(2):86-94. PubMed ID: 26801502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Retinal Vein Occlusion with Ranibizumab in Clinical Practice: Longer-Term Results and Predictive Factors of Functional Outcome.
    Farinha C; Marques JP; Almeida E; Baltar A; Santos AR; Melo P; Costa M; Figueira J; Cachulo ML; Pires I; Silva R
    Ophthalmic Res; 2015; 55(1):10-8. PubMed ID: 26540281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography.
    Fan W; Nittala MG; Fleming A; Robertson G; Uji A; Wykoff CC; Brown DM; van Hemert J; Ip M; Wang K; Falavarjani KG; Singer M; Sagong M; Sadda SR
    Am J Ophthalmol; 2020 Jan; 209():99-106. PubMed ID: 31472160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab combined with grid photocoagulation in recurrent macular edema secondary to retinal vein occlusion.
    Farese E; Cennamo G; Velotti N; Traversi C; Rinaldi M; De Crecchio G
    Eur J Ophthalmol; 2014; 24(5):761-70. PubMed ID: 24585424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Macular Edema Secondary to Vein Occlusion.
    Mimouni M; Segev O; Dori D; Geffen N; Flores V; Segal O
    Am J Ophthalmol; 2017 Oct; 182():160-167. PubMed ID: 28837790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion.
    Salinas-Alamán A; Zarranz-Ventura J; Caire González-Jauregui JM; Sádaba-Echarri LM; Barrio-Barrio J; García-Layana A
    Eur J Ophthalmol; 2011; 21(4):434-9. PubMed ID: 21140369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained Benefits of Ranibizumab with or without Laser in Branch Retinal Vein Occlusion: 24-Month Results of the BRIGHTER Study.
    Tadayoni R; Waldstein SM; Boscia F; Gerding H; Gekkieva M; Barnes E; Das Gupta A; Wenzel A; Pearce I;
    Ophthalmology; 2017 Dec; 124(12):1778-1787. PubMed ID: 28807635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macular function following intravitreal ranibizumab for macular edema associated with branch retinal vein occlusion.
    Nishimura T; Machida S; Tada A; Oshida E; Muto T
    Doc Ophthalmol; 2019 Aug; 139(1):67-74. PubMed ID: 30980231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of combined bevacizumab/targeted photocoagulation vs bevacizumab alone for macular oedema in ischaemic branch retinal vein occlusions.
    Tomomatsu Y; Tomomatsu T; Takamura Y; Gozawa M; Arimura S; Takihara Y; Inatani M
    Acta Ophthalmol; 2016 May; 94(3):e225-30. PubMed ID: 25989706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of short-term visual outcome after anti-VEGF therapy of macular edema due to central retinal vein occlusion.
    Wolf-Schnurrbusch UE; Ghanem R; Rothenbuehler SP; Enzmann V; Framme C; Wolf S
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3334-7. PubMed ID: 21087958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between optic nerve head circulation and visual function before and after anti-VEGF therapy for central retinal vein occlusion: prospective, interventional case series.
    Nagasato D; Mitamura Y; Semba K; Akaiwa K; Nagasawa T; Yoshizumi Y; Tabuchi H; Kiuchi Y
    BMC Ophthalmol; 2016 Apr; 16():36. PubMed ID: 27044276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Off-label" use of intravitreal bevacizumab in non-ischemic macular edema secondary to retinal vein obstructions.
    Dascalu AM; Popa-Cherecheanu A; Popa-Cherecheanu M; Nica A; Serban D
    Rom J Ophthalmol; 2016; 60(2):90-95. PubMed ID: 29450329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.